Showing results (191-200 of 290) with videos related to
Sort By:
Pageof 29
Clinical Chemistry|February 1, 1995
Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIAC M Thomas, L F Massuger, M F Segers, et al.British Journal of Cancer|March 1, 1994
The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinomaT Wobbes, C M Thomas, M F Segers, et al.Fertility and Sterility|September 1, 1991
Retrograde seeding of endometrial epithelial cells by uterine-tubal flushingR F Kruitwagen, L G Poels, W N Willemsen, et al.Biochimica Et Biophysica Acta|November 15, 1996
Thiamine (vitamin B1) supplementation does not reduce fasting blood homocysteine concentration in most homozygotes for homocystinuriaD G Franken, H J Blom, G H Boers, et al.ISRN Obstetrics and Gynecology|December 5, 2012
Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during PregnancyVicki Strugala, Julian Bassin, Valerie S Swales, et al.Journal of Bacteriology|April 28, 1999
IncC of broad-host-range plasmid RK2 modulates KorB transcriptional repressor activity In vivo and operator binding in vitroG Jagura-Burdzy, K Kostelidou, J Pole, et al.Cell|February 9, 1996
The tomato Cf-2 disease resistance locus comprises two functional genes encoding leucine-rich repeat proteinsM S Dixon, D A Jones, J S Keddie, et al.The Journal of Nutrition|August 4, 1998
Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriagesW L Nelen, H J Blom, C M Thomas, et al.Obstetrics and Gynecology|March 22, 2000
Homocysteine and folate levels as risk factors for recurrent early pregnancy lossW L Nelen, H J Blom, E A Steegers, et al.Journal of Medicinal Chemistry|October 16, 1992
Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phthalimidoalkyl and -alkylamino analoguesJ M Hoffman, J S Wai, C M Thomas, et al.Pageof 29